Activating the Wnt/β-Catenin Pathway for the Treatment of Melanoma--Application of LY2090314, a Novel Selective Inhibitor of Glycogen Synthase Kinase-3.

by Jennifer M Atkinson, Kenneth B Rank, Yi Zeng, Andrew Capen, Vipin Yadav, Jason R Manro, Thomas A Engler, Marcio Chedid
Published 2015-01-01

The Glycogen Synthase Kinase-3β Inhibitor LSN 2105786 Promotes Zebrafish Fin Regeneration

by Swapnalee Sarmah, Courtney Curtis, Jennifer Mahin, Mark Farrell, Thomas A. Engler, Manuel V. Sanchez-Felix, Masahiko Sato, Yanfai Linda Ma, Shaoyou Chu, James A. Marrs
Published 2019-04-01